Download PDF
Thromb Haemost 1993; 70(01): 075-079
DOI: 10.1055/s-0038-1646164
State-of-the-Art Lecture
Factor XI
Schattauer GmbH Stuttgart

Factor XI and Platelets: Activation and Regulation

Peter N Walsh
‡   The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA
†   Departments of Medicine and Biochemistry, Temple University School of Medicine, Philadelphia, PA, USA
,
Frank A Baglia
‡   The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA
,
Bradford A Jameson
¶   Thomas Jefferson University, Philadelphia, PA, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Movat HZ, Ozge-Anwar AH. The contact phase of blood coagulation: Clotting factors XI and XII, their isolation and interaction. J Lab Clin Med 1974; 84: 861-78
    PubMedGoogle Scholar
  • 2 Heck LW, Kaplan AP. Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by α1-antitrypsin. J Exp Med 1974; 140: 1615-30
    CrossrefPubMedGoogle Scholar
  • 3 Kurachi K, Davie EW. Activation of human factor XI (plasma thromboplastin antecedent) by factor Xlla (activated Hageman factor). Biochemistry 1977; 16: 5831-39
    CrossrefPubMedGoogle Scholar
  • 4 Bouma BN, Griffin JH. Human blood coagulation factor XI: Purification, properties and mechanisms of activation by activated factor XII. J Biol Chem 1977; 252: 6432-37
    PubMedGoogle Scholar
  • 5 Saito H, Goldsmith G. Plasma thromboplastin antecedent (factor XI): A specific and sensitive radioimmunoassay. Blood 1977; 50: 377-85
    PubMedGoogle Scholar
  • 6 Fujikawa K, Chung DW, Hendrickson LE, Davie EW. Amino acid sequence of human factor XI a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry 1986; 25: 2417-24
    CrossrefPubMedGoogle Scholar
  • 7 McMullen BA, Fujikawa K, Davie EW. Location of the disulfide bonds in human coagulation factor XI: The presence of tandem apple domains. Biochemistry 1991; 30: 2056-60
    CrossrefPubMedGoogle Scholar
  • 8 Ratnoff OD, Davie EW, Mallett DL. Studies on the action of Hageman factor: Evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest 1961; 40: 803-19
    CrossrefPubMedGoogle Scholar
  • 9 Saito H, Ratnoff OD, Marshall JS, Pensky J. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin. J Clin Invest 1973; 52: 850-61
    CrossrefPubMedGoogle Scholar
  • 10 Schiffman S, Lee P. Preparation, characterization and activation of a highly purified factor XI: Evidence that a hitherto unrecognized plasma activity participates in the interaction of factors XI and XII. Br J Haematol 1974; 27: 101-14
    CrossrefPubMedGoogle Scholar
  • 11 Schiffman S, Markland Jr FJ. Effect of intermediates of extrinsic clotting on purified factor XI: Factor VII and/or thromboplastin. Thromb Res 1975; 6: 273-79
    CrossrefPubMedGoogle Scholar
  • 12 Griffin JH, Cochrane CG. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proc Natl Acad Sci USA 1976; 73: 2554-58
    CrossrefPubMedGoogle Scholar
  • 13 Liu CY, Scott CF, Bagdasarian A, Pierce JV, Kaplan AP, Colman RW. Potentiation of the function of Hageman factor fragments by HMW kininogen. J Clin Invest 1977; 60: 7-17
    CrossrefPubMedGoogle Scholar
  • 14 Meier HL, Scott CF, Mandle R, Webster ME, Pierce JV, Colman RW, Kaplan AP. Activation and function of human Hageman factor: The role of high molecular weight kininogen and prekallikrein. J Clin Invest 1977; 60: 18-31
    CrossrefPubMedGoogle Scholar
  • 15 Thompson RE, Mandle Jr R, Kaplan AP. Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest 1977; 60: 1376-80
    CrossrefPubMedGoogle Scholar
  • 16 Wiggins RC, Bouma BN, Cochrane CG, Griffin JH. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation factor XI and prekallikrein. Proc Natl Acad Sci USA 1977; 74: 4636-40
    CrossrefPubMedGoogle Scholar
  • 17 Walsh PN, Griffin JH. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. Blood 1981; 57: 106-18
    PubMedGoogle Scholar
  • 18 Greengard JS, Heeb MJ, Ersdal E, Walsh PN, Griffin JH. Binding of coagulation factor XI to washed human platelets. Biochemistry 1986; 25: 3884-90
    CrossrefPubMedGoogle Scholar
  • 19 Fujikawa K, Legaz ME, Kato H, Davie ER. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent). Biochemistry 1974; 13: 4508-16
    CrossrefPubMedGoogle Scholar
  • 20 DiScipio RG, Kurachi K, Davie EW. Activation of human factor IX (Christmas factor). J Clin Invest 1978; 61: 1528-38
    CrossrefPubMedGoogle Scholar
  • 21 Østerud B, Bouma BN, Griffin JH. Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI. J Biol Chem 1978; 253: 5946-51
    PubMedGoogle Scholar
  • 22 Sinha D, Seaman FS, Walsh PN. Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX. Biochemistry 1987; 26: 3768-75
    CrossrefPubMedGoogle Scholar
  • 23 Rosenthal RL, Dreskin OH, Rosenthal N. New hemophiliac-like disease caused by a deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med 1953; 82: 171-74
    CrossrefPubMedGoogle Scholar
  • 24 Rapaport SI, Proctor RR, Patch MJ, Yettra M. The mode of inheritance of PTA deficiency: Evidence for the existence of major PTA deficiency and minor PTA deficiency. Blood 1961; 18: 149-165
    PubMedGoogle Scholar
  • 25 Leiba H, Ramot B, Many A. Hereditary and coagulation studies in ten families with factor XI (plasma thromboplastin antecedent) deficiency. Br J Haematol 1965; 11: 654-665
    CrossrefPubMedGoogle Scholar
  • 26 Rimon A, Schiffman S, Feinstein DI, Rapaport SI. Factor XI activity and factor XI antigen in homozygous and heterozygous factor XI deficiency. Blood 1976; 48: 165-74
    CrossrefPubMedGoogle Scholar
  • 27 Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor XI coagulant activity and factor XI antigen in twenty-five factor XI deficient kindreds. Blood 1985; 65: 719-24
    PubMedGoogle Scholar
  • 28 Schmaier AH, Silverberg M, Kaplan AP, Colman RW. Contact activation and its abnormalities. In: Hemostasis and Thrombosis. Colman RW, Hirsh J, Marder VJ, and Salzman EW. (eds). JB Lippincott Co.; Philadelphia: 1987. pp. 18-38
    Google Scholar
  • 29 Walsh PN. The effects of collagen and kaolin on the intrinsic coagulant activity of platelets: Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII. Br J Haematol 1972; 22: 393-405
    CrossrefPubMedGoogle Scholar
  • 30 Walsh PN. The role of platelets in the contact phase of blood coagulation. Br J Haematol 1972; 22: 237-54
    CrossrefPubMedGoogle Scholar
  • 31 Walsh PN, Sinha D, Koshy A, Seaman FS, Bradford H. Functional characterization of platelet-bound factor XIa: Retention of factor XIa activity on the platelet surface. Blood 1986; 68: 225-30
    PubMedGoogle Scholar
  • 32 Walsh PN, Sinha D, Kueppers F, Blankstein KB, Seaman FS. Regulation of factor XIa activity by platelets and alpha-1-protease inhibitor. J Clin Invest 1987; 80: 1578-86
    CrossrefPubMedGoogle Scholar
  • 33 Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 1991; 266: 7353-58
    PubMedGoogle Scholar
  • 34 Gailani D, Broze Jr GJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-12
    CrossrefPubMedGoogle Scholar
  • 35 Steinberg M, Nemerson Y. Activation of factor X. In: Hemostasis and Thrombosis.. Colman RW, Hirsh J, Marder VJ, and Salzman EW. (eds). JB Lippincott Co; Philadelphia: 1987. pp. 112-119
    Google Scholar
  • 36 Broze Jr GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539-46
    CrossrefPubMedGoogle Scholar
  • 37 Broze Jr GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VILtissue factor complex also inhibits factor Xa: Insight into its possible mechanism of activation. Blood 1988; 71: 335-43
    PubMedGoogle Scholar
  • 38 Scott CF, Colman RW. Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate. Proc Natl Acad Sci USA 1992; 89: 11189-93
    CrossrefPubMedGoogle Scholar
  • 39 Sinha D, Seaman FS, Koshy A, Knight LC, Walsh PN. Blood coagulation factor XIa binds specially to a site on activated human platelets distinct from that for factor XI. J Clin Invest 1984; 73: 1550-56
    CrossrefPubMedGoogle Scholar
  • 40 Sinha D, Koshy A, Seaman FS, Walsh PN. Functional characterization of human blood coagulation factor XIa using hybridoma antibodies. J Biol Chem 1985; 260: 10714-19
    PubMedGoogle Scholar
  • 41 Cronlund AL, Walsh PN. A low molecular weight platelet inhibitor of factor XIa (PIXI): Purification, characterization and possible role in blood coagulation. Biochemistry 1992; 31: 1685-94
    CrossrefPubMedGoogle Scholar
  • 42 Smith RP, Higuchi DA, Broze Jr GJ. Platelet coagulation factor Xla-inhibitor, a form of Alzheimer amyloid precursor protein. Science 1990; 248: 1126-28
    CrossrefPubMedGoogle Scholar
  • 43 VanNostrand WE, Schmaier AH, Farrow JS, Cunningham DD. Protease nexin-II (amyloid β-protein precursor): A platelet a-granule protein. Science 1990; 248: 745-48
    CrossrefPubMedGoogle Scholar
  • 44 Bush Al, Martins RN, Rumble B, Moir R, Fuller S, Milward E, Currie J, Ames D, Weidemann A, Fischer P, Multhaup G, Beyrenther K, Masters CL. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 1990; 265: 15977-83
    CrossrefPubMedGoogle Scholar
  • 45 Ahmad SS, Rawala-Sheikh R, Walsh PN. Comparative interactions of factor IX and factor IXa with human platelets. J Biol Chem 1989; 264: 3244-51
    PubMedGoogle Scholar
  • 46 Ahmad SS, Rawala-Sheikh R, Walsh PN. Platelet receptor occupancy with factor IXa promotes factor-X activation. J Biol Chem 1989; 264: 20012-16
    PubMedGoogle Scholar
  • 47 Rawala-Sheikh R, Ahmad SS, Ashby B, Walsh PN. Kinetics of coagulation factor X activation by platelet-bound factor IXa. Biochemistry 1990; 29: 2606-11
    CrossrefPubMedGoogle Scholar
  • 48 Scott CF, Schapira M, James HL, Cohen AB, Colman RW. Inactiva-tion of factor XIa by plasma protease inhibitors. Predominant role of αl-protease inhibitor and protective effect of high molecular weight kininogen. J Clin Invest 1982; 69: 844-52
    CrossrefPubMedGoogle Scholar
  • 49 Horowitz HI, Fujimoto MM. Association of factors XI and XII with blood platelets. Proc Soc Exp Biol Med 1965; 119: 487-92
    CrossrefPubMedGoogle Scholar
  • 50 Schiffman S, Rapaport SI, Chong MMY. Platelets and initiation of intrinsic clotting. Br J Haematol 1973; 24: 633-42
    CrossrefPubMedGoogle Scholar
  • 51 Schiffman S, Rimon A, Rapaport SI. Factor XI and platelets: Evidence that the platelets contain only minimal factor XI activity and antigen. Br J Haematol 1977; 35: 429-36
    CrossrefPubMedGoogle Scholar
  • 52 Connellan JM, Muntz RH, Castaldi PA. Factor XI in the coagulant activity of platelets. Haemostasis 1977; 6: 41-52
    PubMedGoogle Scholar
  • 53 Lipscomb MS, Walsh PN. Human platelets and factor XL Localization in platelet membranes of factor-XI-like activity and its functional distinction from plasma factor XI. J Clin Invest 1979; 63: 1006-14
    CrossrefPubMedGoogle Scholar
  • 54 Tuszynski GP, Bevacqua SJ, Schmaier AH, Colman RW, Walsh PN. Factor XI antigen and activity in human platelets. Blood 1982; 59: 1148-56
    PubMedGoogle Scholar
  • 55 Schiffman S, Yeh CH. Purification and characterization of platelet factor XI. Thromb Res 1990; 60: 87-97
    CrossrefPubMedGoogle Scholar
  • 56 Van der Graaf F, Greengard JS, Bouma BN, Kerbiriou DM, Griffin JH. Isolation and functional characterization of the active light chain of activated human blood coagulation factor XL. J Biol Chem 1983; 258: 9669-75
    PubMedGoogle Scholar
  • 57 Akiyama H, Sinha D, Seaman FS, Kirby EP, Walsh PN. Mechanism of activation of coagulation factor XI by factor Xlla studied with monoclonal antibodies. J Clin Invest 1986; 78: 1631-37
    CrossrefPubMedGoogle Scholar
  • 58 Baglia FA, Sinha D, Walsh PN. Functional domains in the heavy chain region of factor XL A high molecular weight kininogen-bind-ing site and a substrate-binding site for factor IX. Blood 1989; 74: 244-51
    PubMedGoogle Scholar
  • 59 Baglia FA, Jameson BA, Walsh PN. Localization of the high molecular weight kininogen binding site in the heavy chain of human factor XI to amino acids Phe56 through Ser86 . J Biol Chem 1990; 265: 4149-54
    PubMedGoogle Scholar
  • 60 Baglia FA, Jameson BA, Walsh PN. Fine mapping of the high molecular weight kininogen binding site on blood coagulation factor XI through the use of rationally designed synthetic analogs. J Biol Chem 1992; 267: 4247-52
    PubMedGoogle Scholar
  • 61 Baglia FA, Jameson BA, Walsh PN. Identification and chemical synthesis of a substrate binding site for factor IX on coagulation factor XIa. J Biol Chem 1991; 266: 24190-97
    PubMedGoogle Scholar
  • 62 Baglia FA, Jameson BA, Walsh PN. Identification and characterization of a binding site for factor XIIa in the Apple 4 domain of coagulation factor XL. J Biol Chem 1993; 268: 3838-44
    CrossrefPubMedGoogle Scholar
  • 63 Meijers JCM, Mulvihill ER, Davie EW, Chung DW. Apple four in human blood coagulation factor XI mediates dimer formation. Biochemistry 1992; 31: 4680-84
    CrossrefPubMedGoogle Scholar